EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research Status and Prospect of Non-Viral Vectors Based on siRNA: A Review

Liangnan Tong, Danqing Liu, Zhiyue Cao, Nannan Zheng, Chenchen Mao, Shujuan Liu, Liangcan He iD, Shaoqin Liu

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24043375 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Liangnan Tong und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Material Science and Chemical Engineering, Harbin University of Science and Technology, Harbin 150040, China. Hauptthemen laut MEDLINE: Hepatitis B, Nucleic Acids. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural and Science Foundation of China, Key Laboratory of Micro-systems and Micro-structures Manufacturing (Harbin Institute of Technology), Ministry of Education, Natural Science Foundation of Heilongjiang Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene therapy has attracted much attention because of its unique mechanism of action, non-toxicity, and good tolerance, which can kill cancer cells without damaging healthy tissues. siRNA-based gene therapy can downregulate, enhance, or correct gene expression by introducing some nucleic acid into patient tissues. Routine treatment of hemophilia requires frequent intravenous injections of missing clotting protein. The high cost of combined therapy causes most patients to lack the best treatment resources. siRNA therapy has the potential of lasting treatment and even curing diseases. Compared with traditional surgery and chemotherapy, siRNA has fewer side effects and less damage to normal cells. The available therapies for degenerative diseases can only alleviate the symptoms of patients, while siRNA therapy drugs can upregulate gene expression, modify epigenetic changes, and stop the disease. In addition, siRNA also plays an important role in cardiovascular diseases, gastrointestinal diseases, and hepatitis B. However, free siRNA is easily degraded by nuclease and has a short half-life in the blood. Research has found that siRNA can be delivered to specific cells through appropriate vector selection and design to improve the therapeutic effect. The application of viral vectors is limited because of their high immunogenicity and low capacity, while non-viral vectors are widely used because of their low immunogenicity, low production cost, and high safety. This paper reviews the common non-viral vectors in recent years and introduces their advantages and disadvantages, as well as the latest application examples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis BNucleic AcidsHumansRNA, Small InterferingGenetic TherapyHalf-LifeGenetic Vectors

Stichwörter der Autor:innen

biomedical applicationgene therapynon-viral vectorssiRNA delivery

Substanzen

RNA, Small InterferingNucleic Acids

Autor:innen und Institutionen

  • School of Material Science and Chemical Engineering, Harbin University of Science and Technology, Harbin 150040, China.
  • School of Life Science and Technology, Harbin Institute of Technology, Harbin 150001, China.
  • School of Medicine and Health, Harbin Institute of Technology, Harbin 150001, China.
  • Department of Electrical, Computer and Energy Engineering, University of Colorado Boulder, Boulder, CO 80309, USA.
  • School of Materials Science and Engineering, Harbin Institute of Technology, Harbin 150001, China.
  • Key Laboratory of Microsystems and Microstructures Manufacturing (Ministry of Education), Harbin Institute of Technology, Harbin 150001, China.

ORCID-Profile: Liangcan He

Förderung

  • National Natural and Science Foundation of China
  • Key Laboratory of Micro-systems and Micro-structures Manufacturing (Harbin Institute of Technology), Ministry of Education
  • Natural Science Foundation of Heilongjiang Province of China
  • Heilongjiang Touyan Innovation Team Program
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Tong, L., Liu, D., Cao, Z., Zheng, N., Mao, C., Liu, S., He, L., & Liu, S. (2023). Research Status and Prospect of Non-Viral Vectors Based on siRNA: A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043375

Vancouver

Tong L, Liu D, Cao Z, Zheng N, Mao C, Liu S, et al. Research Status and Prospect of Non-Viral Vectors Based on siRNA: A Review. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043375

BibTeX
@article{Tong2023,
  author = {Tong, Liangnan and Liu, Danqing and Cao, Zhiyue and Zheng, Nannan and Mao, Chenchen and Liu, Shujuan and He, Liangcan and Liu, Shaoqin},
  title = {Research Status and Prospect of Non-Viral Vectors Based on siRNA: A Review},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24043375}
}
Kostenlos starten →